Source: Annual Congress 2012 - Fungal, viral and other infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. George, D. Garcha, A. Patel, A. Mackay, R. Singh, R. Sapsford, G. Donaldson, W. Wedzicha (Hampstead, United Kingdom). The prevalence of clinically relevant micro-organisms in stable and exacerbated COPD using PCR techniques. Eur Respir J 2012; 40: Suppl. 56, 1915

Member's Comments

No comment yet.

Related content which might interest you: Comparison of quantitative PCR and quantitative culture for the detection of airway pathogenic bacteria in COPD Source: International Congress 2014 – Markers Year: 2014 Rapid detection of major respiratory tract viral infections in acute exacerbation of COPD by highly sensitive multiplex PCR (mPCR) Source: Annual Congress 2013 –Viral infections Year: 2013 PCR based method for accurate diagnosis of mycobacterial disease and description of clinical profile of disease caused by non tuberculous mycobacteria Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Identification of causative bacteria in the airways of COPD by a novel semi-quantitative PCR method Source: Annual Congress 2013 –COPD and infections Year: 2013 Microbiological pattern and risk factors of bacterial colonisation in patients with clinically stable brochiectasis Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 The role of bacterial pathogens in exacerbation of COPD assessed by microbiological method and polymerase chain reaction Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 The effect of different tools in assessing the prevalence of depression in COPD patients Source: Annual Congress 2008 - Quality of life and mood disturbances in rehabilitation Year: 2008 Does presence of multiple viruses in the stable state predispose COPD patients to exacerbations? Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Most frequent infecting agents caused acute exacerbation of COPD and their suspectability to the different types of penicillins Source: Eur Respir J 2002; 20: Suppl. 38, 545s Year: 2002 A study of the relation of microbiological etiology with analytical and clinical parameters in exacerbation of COPD Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 PCR is a sensitive and specific method for the laboratory diagnosis of mycoplasma pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 220s Year: 2002 Clinically relevant subgroups in COPD and asthma Source: Eur Respir Rev 2015; 24: 283-298 Year: 2015 The subclinical atherosclerosis and its association to clinical features of stable COPD Source: Annual Congress 2011 - COPD management Year: 2011 Physical inactivity in patients with COPD: prevalence and clinically relevant effects Source: Annual Congress 2013 –Physical activity as the panacea for COPD Year: 2013 Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 The clinical value of initial microbiological studies in exacerbations of COPD is questionable and not affected by antibiotics prior to hospitalization Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001 Most frequent bacterial agents and antimicrobal therapy in patients with different types of acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003 Common and atypical pathogens in severe COPD exacerbations and predictors of positive sputum cultures Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Impact and economic burden observed in asthma patients considered as mild: an analysis of the respiratory disease specific programme I Source: Annual Congress 2003 - Burden of asthma Year: 2003 Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019